These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35377505)

  • 1. Impact of VDR and RXR expression in non-melanoma skin cancer pathogenesis.
    Ocanha-Xavier JP; Xavier JCC; Guimarães da Silva M; Marques MEA
    Exp Dermatol; 2022 Aug; 31(8):1202-1207. PubMed ID: 35377505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D3 receptor and retinoid X receptors in psoriatic skin: the receptor levels correlate with the receptor binding to DNA.
    Jensen T; Sørensen S; Sølvsten H; Kragballe K
    Br J Dermatol; 1998 Feb; 138(2):225-8. PubMed ID: 9602865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
    Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol potentiates vitamin D and nuclear receptor signaling.
    Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
    J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL; Kurian S; Farmer P; Nanes MS
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):65-72. PubMed ID: 9723887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors.
    Prüfer K; Racz A; Lin GC; Barsony J
    J Biol Chem; 2000 Dec; 275(52):41114-23. PubMed ID: 11001945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
    Lemon BD; Freedman LP
    Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer.
    Yasmin R; Williams RM; Xu M; Noy N
    J Biol Chem; 2005 Dec; 280(48):40152-60. PubMed ID: 16204233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
    Prüfer K; Barsony J
    Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
    Xu XC; Wong WY; Goldberg L; Baer SC; Wolf JE; Ramsdell WM; Alberts DS; Lippman SM; Lotan R
    Cancer Res; 2001 Jun; 61(11):4306-10. PubMed ID: 11389049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant Association of Poly-A and Fok1 Polymorphic Alleles of the Vitamin D Receptor with Vitamin D Serum Levels and Incidence of Squamous Cutaneous Neoplasia.
    Bullock TA; Mack JA; Negrey J; Kaw U; Hu B; Anand S; Hasan T; Warren CB; Maytin EV
    J Invest Dermatol; 2023 Aug; 143(8):1538-1547. PubMed ID: 36813159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.